Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Tumor Initiation topic
No spam. Unsubscribe anytime.
Researchers trace early premalignant programs and spotlight a bottleneck in progression
Summary
Speakers reported that premalignant epithelial cells can show molecular abnormality and communication programs long before histologic change; lineage and modeling data point to a growth bottleneck between initiated field and nascent lesion as a key barrier to overt tumors.
Presentations at the NCI workshop emphasized that cells with abnormal molecular programs can reside in histologically normal tissue and that microenvironmental signals help determine whether those cells progress.
Ken Lau (Vanderbilt) summarized single‑cell and spatial data from colorectal and esophageal tissues showing molecularly abnormal epithelial populations — including cell identities resembling pyloric or fetal programs — that appear sporadically in morphologically normal tissue and expand in settings of damage and inflammation. "These cells are molecularly abnormal, but morphologically normal," Lau said, and added that distinct cells of origin and driver mutations produce different interactions with T cells in mouse models.
Complementary single‑cell time series in a Kras‑driven pancreatic model (presented by Cassandra) showed that within 24 hours after induced pancreatitis the chromatin landscape is rapidly reprogrammed and diverse high‑plasticity epithelial transcriptional phenotypes emerge, including programs linked to cell–cell communication. Cassandra reported that computational reconstruction of cell–cell signaling networks identified feedback loops between plastic epithelial cells and regulatory T cells that may sustain reprogramming.
Meanwhile, lineage‑tracing 'rainbow' models in mice (Josh Snyder, Duke) showed that engineered fields of initiated cells can be large yet only rarely yield palpable tumors. Modeling of those data suggests the primary rate‑limiting step lies in the transition from an initiated field to a nascent, screen‑detectable lesion; once that step is crossed, progression to a palpable tumor becomes much more likely.
Why it matters: these results refract a simple clinical observation — many adults harbor somatic mutations or small premalignant clones that never progress — into testable mechanistic hypotheses: (1) some premalignant states are defined by chromatin priming and enhanced communication capacity; (2) progression depends on microenvironmental feedback and a specific growth bottleneck; (3) interventions that alter local signaling or tissue geometry could change progression probability.
Next steps proposed included perturbation experiments that combine spatially targeted genetic activation with engineered microenvironments, and standardized measures to compare organoid, explant and in vivo results.
